Production of Viable Cloned Miniature Pig Embryos Using Oocytes Derived from Domestic Pig Ovaries
Overview
Cell Biology
Genetics
Authors
Affiliations
For production of viable somatic cell nuclear transferred (SCNT) miniature pig embryos, in vitro condition for controlling the quality of recipient oocytes derived from domestic pig ovaries should be evaluated. In the present study, to get information on optimal in vitro maturation (IVM) condition of oocytes, we investigated the effect of IVM duration of recipient oocytes on subsequent development of SCNT miniature pig embryos, the maturation-promoting factor (MPF) activity in recipient oocytes before and after SCNT, and the occurrence of premature chromosome condensation (PCC) and spindle morphologies of donor nuclei following SCNT. The optimal window of the IVM period in terms of in vitro developmental ability of SCNT embryos was determined to be 36-40 h after the start of IVM. The use of recipient oocytes matured for 36 and 40 h resulted in a high level of MPF activity before and after SCNT, and increased the occurrence of PCC in transferred nuclei compared to the use of oocytes matured for 44 and 52 h. The proportion of abnormal spindle-like structures increased as the IVM period was prolonged. In addition, SCNT embryos constructed from recipient cytoplasts obtained after 40 h of maturation by using fetal fibroblasts of miniature pigs were transferred to surrogate miniature pigs, and developed to full term. These results suggest that recipient oocytes matured for 36 h and 40 h effectively induce PCC with a normal cytoskeletal structure because of a high level of MPF activity; furthermore, the 40-h IVM period improves in vitro development of SCNT embryos to the blastocyst stage, resulting in the production of viable cloned miniature pigs.
Efficacy of the porcine species in biomedical research.
Gutierrez K, Dicks N, Glanzner W, Agellon L, Bordignon V Front Genet. 2015; 6:293.
PMID: 26442109 PMC: 4584988. DOI: 10.3389/fgene.2015.00293.
Shimatsu Y, Yamada K, Horii W, Hirakata A, Sakamoto Y, Waki S Xenotransplantation. 2013; 20(3):157-64.
PMID: 23581451 PMC: 3815503. DOI: 10.1111/xen.12031.
Nasu M, Nakahara T, Tominaga N, Tamaki Y, Ide Y, Tachibana T In Vitro Cell Dev Biol Anim. 2013; 49(3):189-95.
PMID: 23435856 DOI: 10.1007/s11626-013-9584-6.
Kobayashi E, Hishikawa S, Teratani T, T Lefor A Transplant Res. 2013; 1(1):8.
PMID: 23369409 PMC: 3560993. DOI: 10.1186/2047-1440-1-8.
Zhao J, Ross J, Hao Y, Spate L, Walters E, Samuel M Biol Reprod. 2009; 81(3):525-30.
PMID: 19386991 PMC: 2731980. DOI: 10.1095/biolreprod.109.077016.